NEW YORK, Jan. 20, 2015 /PRNewswire-USNewswire/ -- The Fisher Center for Alzheimer's Research Foundation debuts its new cross-platform website with a bold entreaty: We Can End Alzheimer's.
While there is currently no cure for Alzheimer's, the Foundation has made unique and groundbreaking progress in the global quest for a cure. Nobel Laureate Dr. Paul Greengard leads its research team of more than 50 world-renowned scientists.
"Our reinvigorated website now offers a deep well of resources for all those affected by Alzheimer's, and allows visitors to follow our research progress in developing new treatment protocols, and ultimately finding a cure, for this debilitating disease," said Kent L. Karosen, President/CEO Fisher Center for Alzheimer's Research Foundation.
The number of people diagnosed with Alzheimer's disease is expected to double worldwide by 2030, making it a critical public-health concern that affects every part of the globe, and every gender, ethnicity and socioeconomic bracket. The promising new research findings of the Fisher Center lab offers new hope that this worldwide trend can be countered.
The new ALZinfo.org offers easy access to critical information for all stakeholders, and a way to connect to a robust community of medical professionals, caregivers and other Alzheimer's patients and their families via all social media platforms.
Marcy Q. Samet, EVP, Chief Growth Officer/Healthcare Practice Lead at MRM//McCann said, "The goal for this new site is to offer a deep well of research, information and resources for all those affected by Alzheimer's. Our hope with ALZinfo.org is to reinforce the need to find a cure for this epidemic. We were thrilled to contribute our key talent and expertise as a global customer-experience marketing agency to redesign the platform and user experience for site visitors looking both to find support and to provide support toward finding a cure for this truly international disease."
About the Fisher Center for Alzheimer's Research Foundation
The Fisher Center for Alzheimer's Research is headquartered in New York City and funds, primarily, the research of Nobel Laureate Dr. Paul Greengard and his team of scientists, in collaboration with other leading research institutions around the world. For more than a decade, Greengard's team has led the way in conducting the seminal research that has shaped the conceptual framework for modern-day investigations into Alzheimer's disease.
To date, the Foundation has provided more than $30 million in research funding to understand the causes of, and find a cure for, Alzheimer's. The Foundation is committed to exemplary fiscal stewardship, and is proud to have earned the highest 4-Star rating from Charity Navigator eight times in the last 12 years.
MRM//McCann is a global customer-experience marketing agency, part of the Interpublic Group (NYSE: IPG). We simplify the complex — helping our clients navigate, transform and gain competitive advantage in today's multidimensional, digitally driven world. We achieve this through creative ideas born at the intersection of technology solutions, measurable performance and our unique understanding of consumer behavior. This philosophy guides our approach to creating innovative experiences that matter to both people and brands. The agency has 30+ offices across North America, Latin America, Europe, the Middle East and Asia-Pacific. For more information, please visit www.mrm-mccann.com.
Kent L. Karosen
President and CEO
SOURCE Fisher Center for Alzheimer's Research Foundation